Literature DB >> 32030409

Rate and Extent of Recovery from Reproductive and Cardiac Dysfunction Due to Androgen Abuse in Men.

Nandini Shankara-Narayana1, Christopher Yu2, Sasha Savkovic1, Reena Desai1, Carolyn Fennell1, Leo Turner1, Veena Jayadev1, Ann J Conway1, Maaike Kockx2, Lloyd Ridley3, Len Kritharides2, David J Handelsman1.   

Abstract

CONTEXT: Androgen abuse impairs male reproductive and cardiac function, but the rate, extent, and determinants of recovery are not understood.
OBJECTIVE: To investigate recovery of male reproductive and cardiac function after ceasing androgen intake in current and past androgen abusers compared with healthy non-users.
METHODS: Cross-sectional, observational study recruited via social media 41 current and 31 past users (≥3 months since last use, median 300 days since last use) with 21 healthy, eugonadal non-users. Each provided a history, examination, and serum and semen sample and underwent testicular ultrasound, body composition analysis, and cardiac function evaluation.
RESULTS: Current abusers had suppressed reproductive function and impaired cardiac systolic function and lipoprotein parameters compared with non- or past users. Past users did not differ from non-users, suggesting full recovery of suppressed reproductive and cardiac functions after ceasing androgen abuse, other than residual reduced testicular volume. Mean time to recovery was faster for reproductive hormones (anti-Mullerian hormone [AMH], 7.3 months; luteinizing hormone [LH], 10.7 months) than for sperm variables (output, 14.1 months) whereas spermatogenesis (serum follicle-stimulating hormone [FSH], inhibin B, inhibin) took longer. The duration of androgen abuse was the only other variable associated with slower recovery of sperm output (but not hormones).
CONCLUSION: Suppressed testicular and cardiac function due to androgen abuse is effectively fully reversible (apart from testis volume and serum sex hormone binding globulin) with recovery taking between 6 to 18 months after ceasing androgen intake with possible cumulative effects on spermatogenesis. Suppressed serum AMH, LH, and FSH represent convenient, useful, and underutilized markers of recovery from androgen abuse. © Crown copyright 2020.

Entities:  

Keywords:  anabolic steroid; androgen abuse; cardiac function; drug abuse; reproductive function; testosterone

Year:  2020        PMID: 32030409     DOI: 10.1210/clinem/dgz324

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Recovery of Reproductive and Cardiac Function in Past Androgen Users.

Authors:  Christina Wang
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

Review 2.  Testosterone Replacement Therapy in Hypogonadal Men.

Authors:  Christina Wang; Ronald S Swerdloff
Journal:  Endocrinol Metab Clin North Am       Date:  2022-02-08       Impact factor: 4.741

Review 3.  Understanding and managing the suppression of spermatogenesis caused by testosterone replacement therapy (TRT) and anabolic-androgenic steroids (AAS).

Authors:  Ankit Desai; Musaab Yassin; Axel Cayetano; Tharu Tharakan; Channa N Jayasena; Suks Minhas
Journal:  Ther Adv Urol       Date:  2022-06-26

Review 4.  Male infertility due to testicular disorders.

Authors:  Aditi Sharma; Suks Minhas; Waljit S Dhillo; Channa N Jayasena
Journal:  J Clin Endocrinol Metab       Date:  2021-01-23       Impact factor: 5.958

Review 5.  Harm Reduction in Male Patients Actively Using Anabolic Androgenic Steroids (AAS) and Performance-Enhancing Drugs (PEDs): a Review.

Authors:  Alex K Bonnecaze; Thomas O'Connor; Cynthia A Burns
Journal:  J Gen Intern Med       Date:  2021-05-04       Impact factor: 6.473

Review 6.  Anabolic-Androgenic Steroid Misuse: Mechanisms, Patterns of Misuse, User Typology, and Adverse Effects.

Authors:  Jack B Ding; Marcus Z Ng; Steven S Huang; Mark Ding; Kevin Hu
Journal:  J Sports Med (Hindawi Publ Corp)       Date:  2021-12-10

7.  Reliability of Drug History to Verify Androgen Abuse in Men.

Authors:  Nandini Shankara-Narayana; Lance Brooker; Catrin Goebel; Naomi Speers; David J Handelsman
Journal:  J Clin Endocrinol Metab       Date:  2022-08-18       Impact factor: 6.134

8.  Androgen Suppresses In Vivo and In Vitro LH Pulse Secretion and Neural Kiss1 and Tac2 Gene Expression in Female Mice.

Authors:  Lourdes A Esparza; Tomohiro Terasaka; Mark A Lawson; Alexander S Kauffman
Journal:  Endocrinology       Date:  2020-12-01       Impact factor: 4.736

Review 9.  Anabolic androgenic steroid abuse in young males.

Authors:  Willem de Ronde; Diederik L Smit
Journal:  Endocr Connect       Date:  2020-03-01       Impact factor: 3.335

Review 10.  The Illusory Case for Treatment of an Invented Disease.

Authors:  David J Handelsman
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-18       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.